Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of NF- κB/NLRP3 pathways in inflammatory endothelial cells

Atherosclerosis, a chronic inflammatory disease characterized by arterial plaque formation, is one of the most prominent causes of cardiovascular diseases. However, the current treatments often do not adequate...

Source: Journal of Nanobiotechnology - November 30, 2023 Category: Nanotechnology Authors: Juan Tang, Tao Li, Xiaojing Xiong, Qiaoyun Yang, Zedazhong Su, Minming Zheng and Qingwei Chen Tags: Research Source Type: research